Tailored porous silicon microparticles: fabrication and properties.

The use of mesoporous silicon particles for drug delivery has been widely explored thanks to their biodegradability and biocompatibility. The ability to tailor the physicochemical properties of porous silicon at the micro- and nanoscale confers versatility to this material. A method for the fabrication of highly reproducible, monodisperse, mesoporous silicon particles with controlled physical characteristics through electrochemical etching of patterned silicon trenches is presented. The particle size is tailored in the micrometer range and pore size in the nanometer range, the shape from tubular to discoidal to hemispherical, and the porosity from 46 to over 80%. In addition, the properties of the porous matrix are correlated with the loading of model nanoparticles (quantum dots) and their three-dimensional arrangement within the matrix is observed by transmission electron microscopy tomography. The methods developed in this study provide effective means to fabricate mesoporous silicon particles according to the principles of rational design for therapeutic vectors and to characterize the distribution of nanoparticles within the porous matrix.

[1]  M. Delano,et al.  Emerging implications of nanotechnology on cancer diagnostics and therapeutics , 2006, Cancer.

[2]  P. Chow,et al.  A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device--a first-in-man study. , 2007, International journal of radiation oncology, biology, physics.

[3]  Michael J Sailor,et al.  Biomolecular screening with encoded porous-silicon photonic crystals , 2002, Nature Materials.

[4]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[5]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[6]  Elazer R. Edelman,et al.  Adv. Drug Delivery Rev. , 1997 .

[7]  M. Sailor,et al.  Digital microfluidics and delivery of molecular payloads with magnetic porous silicon chaperones. , 2008, Dalton transactions.

[8]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[9]  Leigh T. Canham,et al.  Derivatized Porous Silicon Mirrors: Implantable Optical Components with Slow Resorbability , 2000 .

[10]  M Ferrari,et al.  Acute Toxicity of Intravenously Administered Microfabricated Silicon Dioxide Drug Delivery Particles in Mice , 2005, Drugs in R&D.

[11]  J. Weidner.  Drug delivery. , 2001, Drug discovery today.

[12]  L. Canham.  Bioactive silicon structure fabrication through nanoetching techniques , 1995 .

[13]  W. Freeman,et al.  Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle , 2008, British Journal of Ophthalmology.

[14]  Nicolas H Voelcker,et al.  Evaluation of mammalian cell adhesion on surface-modified porous silicon. , 2006, Biomaterials.

[15]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[16]  Mauro Ferrari,et al.  The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. , 2009, Biomaterials.

[17]  Leigh T. Canham,et al.  Properties of Porous Silicon , 1998 .

[18]  Joseph M DeSimone,et al.  Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.

[19]  A. Loni,et al.  Mesoporous silicon: a platform for the delivery of therapeutics , 2007, Expert opinion on drug delivery.

[20]  M. Ferrari,et al.  Microfabrication of Silicon-Based Nanoporous Particulates for Medical Applications , 2003 .

[21]  M Ferrari,et al.  The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. , 2008, Journal of biomechanics.

[22]  M Ferrari,et al.  The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. , 2007, Biomaterials.

[23]  C. Tanford.  Macromolecules , 1994, Nature.

[24]  R. Vaia,et al.  Morphology of Layered Silicate− (NanoClay−) Polymer Nanocomposites by Electron Tomography and Small-Angle X-ray Scattering , 2008 .

[25]  Z. Hall.  Cancer , 1906, The Hospital.

[26]  R. Misra,et al.  Biomaterials , 2008 .

[27]  Shuming Nie,et al.  Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.

[28]  S. C. Bayliss,et al.  The Culture of Mammalian Cells on Nanostructured Silicon , 1999 .

[29]  Michael J. Sailor,et al.  Compatibility of Primary Hepatocytes with Oxidized Nanoporous Silicon , 2001 .

[30]  David J. Wallis,et al.  Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions , 2003 .

[31]  V. Lehto,et al.  Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[33]  X. G. Zhang.  Morphology and Formation Mechanisms of Porous Silicon , 2004 .

[34]  Sean D. Graney,et al.  Micropatterning of Porous Silicon Films by Direct Laser Writing , 2008, Biotechnology progress.

[35]  Mauro Ferrari,et al.  Design maps for nanoparticles targeting the diseased microvasculature. , 2008, Biomaterials.

[36]  C. Kübel,et al.  Recent Advances in Electron Tomography: TEM and HAADF-STEM Tomography for Materials Science and Semiconductor Applications , 2005, Microscopy and Microanalysis.

[37]  Philippe M. Fauchet,et al.  Porous silicon as a cell interface for bone tissue engineering , 2007 .